Serum concentrations of sex hormone-binding globulin (SHBG), corticost
eroid binding globulin (CBG), ceruloplasmin, lipoprotein A and liver e
nzymes were measured in 30 postmenopausal women treated with 2 mg micr
onized 17beta-estradiol daily and micronized progesterone orally in do
ses of 50, 100 and 200 mg daily, as progestogen supplementation. The t
reatment lasted for 4 months. The serum levels of SHBG and CBG increas
ed during treatment and a weak association between progesterone dosage
and CBG was observed. Levels of lipoprotein A and liver enzymes did n
ot change. It is concluded that micronized natural progesterone is an
attractive means of progestogen supplementation in postmenopausal horm
one replacement therapy without any liver-related side-effects.